Docoh
Loading...

CRBU Caribou Biosciences

Company profile

Ticker
CRBU
Exchange
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
453728228

CRBU stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

31 Jul 21
31 Dec 21
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
27 Jul 21 FMR Common Stock Conversion Aquire C Yes No 0 1,464,775 0 1,464,775
27 Jul 21 FMR Common Stock Conversion Aquire C Yes No 0 17,572 0 17,572
27 Jul 21 FMR Common Stock Conversion Aquire C Yes No 0 1,070,427 0 1,840,937
27 Jul 21 FMR Common Stock Conversion Aquire C Yes No 0 770,510 0 770,510
27 Jul 21 FMR Series A-1 Preferred Stock Common Stock Conversion Dispose C Yes No 0 805,707 0 0
27 Jul 21 FMR Series A-1 Preferred Stock Common Stock Conversion Dispose C Yes No 0 9,666 0 0
27 Jul 21 FMR Series A-1 Preferred Stock Common Stock Conversion Dispose C Yes No 0 588,794 0 0
27 Jul 21 FMR Series B Preferred Stock Common Stock Conversion Dispose C Yes No 0 423,823 0 0

Financial report summary

?

Financial reports

No filings

Proxies

No filings

Patents

APP
Utility
Suicide Module Compositions and Methods
15 Jul 21
Chimeric transmembrane proteins comprising one or more suicide modules and methods of making and using these constructs are disclosed.
APP
Utility
Modified Cascade Ribonucleoproteins and Uses Thereof
10 Jun 21
A clustered regularly interspaced short palindromic repeat (CRISPR)-associated complex for adaptive antiviral defence (Cascade); the Cascade protein complex comprising at least CRISPR-associated protein subunits Cas7, Cas5 and Cash which includes at least one subunit with an additional amino acid sequence possessing nucleic acid or chromatin modifying, visualising, transcription activating or transcription repressing activity.
GRANT
Utility
Humanized BCMA antibody and BCMA-CAR-T cells
1 Jun 21
The present invention is directed to a humanized BCMA single-chain variable fragment (scFv), comprising VH having the amino acid sequence of SEQ ID NO: 3 and VL having the amino acid sequence of SEQ ID NO: 5.
APP
Utility
Humanized Bcma Antibody and Bcma-car-t Cells
27 May 21
The present invention is directed to a humanized BCMA single-chain variable fragment (scFv), comprising VH having the amino acid sequence of SEQ ID NO: 3 and VL having the amino acid sequence of SEQ ID NO: 5.
GRANT
Utility
Engineered nucleic acid-targeting nucleic acids
11 May 21
The present disclosure provides engineered Class 2 CRISPR-Cas-associated discontinuous first-stem nucleic-acid targeting nucleic acids, nucleoprotein complexes comprising these nucleic acids, and compositions thereof.